Insiders · ALBO

David Chiswell

Director at Albireo Pharma, Inc. (ALBO)

David Chiswell has filed 3 insider reports with the SEC since June 2021, as director at Albireo Pharma, Inc. (ALBO). The latest filing, on March 3, 2023, reports sale back to the company and tender of shares in a change of control at Albireo Pharma, Inc. (ALBO).

Filings
3
Companies
1
Bought on market
None
Sold on market
None

Companies where David Chiswell is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Albireo Pharma, Inc. logo
ALBO
Albireo Pharma, Inc.
Director0Mar 3, 2023

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare David Chiswell with

Questions about David Chiswell

What is David Chiswell's role at Albireo Pharma, Inc.?
David Chiswell reports to the SEC as director at Albireo Pharma, Inc. (ALBO), according to the latest filing on March 3, 2023.
Has David Chiswell bought or sold stock recently?
No open-market purchases or sales by David Chiswell are on file. The filings report sale back to the company, tender of shares in a change of control and grant or award.
How do I get alerts when David Chiswell files?
Follow David Chiswell on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by David Chiswell (SEC CIK 0001687093). Totals count each trade once, skipping amendments whose original is on file, from Jun 28, 2021 on. View on SEC EDGAR · Get this as JSON